跳至主要内容
临床试验/NCT04821505
NCT04821505已完成2 期

Stress Reduction and Hypertension Prevention in African Americans

Maharishi International University0 个研究点目标入组 304 人开始时间: 1998年5月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
304
主要终点
Blood pressure

研究概览

简要总结

There are major health disparities in Blacks associated with high blood pressure (BP) and psychosocial stress. We evaluated the effects of lifestyle modification with meditation in Black adults with high normal and normal blood pressure.

Participants (n=304) were randomized to either the Transcendental Meditation technique or Health Education control in addition to usual care for up to 36 months for BP and secondary outcomes.

详细描述

Background: Blacks suffer from disparities in hypertension, cardiovascular disease (CVD) and currently, coronavirus-19. These conditions are associated with social determinants of health and psychosocial stress. While previous trials demonstrated stress reduction lowering blood pressure in grade I range in Blacks, there is a paucity of clinical trial data in Blacks with high normal and normal BP.

Objective

This randomized controlled trial was conducted to evaluate the effect of stress reduction with the Transcendental Meditation (TM) technique in Black adults with high normal BP and normal BP using International Society of Hypertension (ISH) definitions.

Methods: A total of 304 Black adults with high normal (130-139/85-89 mm Hg) and normal BP (120-129/80-84 mm Hg) were randomized to either TM or health education (HE) arms. BP was recorded at 3, 6, 9, 12, 24, 30, and 36 months after baseline. Linear mixed model analysis was conducted to compare the BP change between TM and HE participants in the high-normal BP and normal-BP groups. Survival analysis for hypertensive events was conducted.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

This is a single-blind randomized controlled trial with all data collection personnel and investigators blinded to subjects' treatment status. The study coordinator does not collect data but receives subjects assigned treatment and then to informs them of their treatment group

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • self-identified Black women and men
  • no current antihypertensive medications
  • high normal BP (130-139 mm Hg and/or DBP 85-89 mm Hg) OR
  • normal BP (SBP 120-129 mm Hg and/DBP 80-84 mm Hg)

排除标准

  • use of antihypertensive medications within the previous 2 months
  • history of CVD, ie, myocardial infarction, angina, peripheral artery disease, heart failure, stroke, or renal failure, diabetes, major psychiatric or substance use disorder other life-threatening illness
  • lack of signed a consent form

结局指标

主要结局

Blood pressure

时间窗: baseline 0 to 36 months after baseline

Both systolic and diastolic BP are measured using standard clinical trial technique recommended by the American Heart Association (AHA)

次要结局

  • Heart rate(baseline 0 to 36 months after baseline)
  • Anger(baseline 0 to 36 months after baseline)
  • Hypertensive events(baseline 0 to 36 months after baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Schneider, MD

Director and Dean

Maharishi International University

相似试验

Stress Reduction and Hypertension Prevention in... | 临床试验